ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 128 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $5,518,000 | -31.2% | 213,625 | -36.3% | 0.76% | -37.5% |
Q1 2018 | $8,018,000 | +68.4% | 335,500 | +138.8% | 1.22% | +117.7% |
Q4 2017 | $4,762,000 | +94.8% | 140,500 | +21.6% | 0.56% | +60.2% |
Q3 2017 | $2,445,000 | -28.5% | 115,500 | -40.9% | 0.35% | -39.9% |
Q2 2017 | $3,419,000 | -0.1% | 195,500 | 0.0% | 0.58% | -13.2% |
Q1 2017 | $3,421,000 | -25.0% | 195,500 | -27.6% | 0.67% | -42.1% |
Q4 2016 | $4,563,000 | +3.0% | 270,000 | 0.0% | 1.16% | +60.2% |
Q3 2016 | $4,431,000 | +8.4% | 270,000 | 0.0% | 0.72% | -32.0% |
Q2 2016 | $4,088,000 | +4.7% | 270,000 | 0.0% | 1.06% | +25.4% |
Q1 2016 | $3,904,000 | -8.1% | 270,000 | +80.0% | 0.85% | +36.0% |
Q4 2015 | $4,248,000 | – | 150,000 | – | 0.62% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |